Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API + Credits


logo
BioNTech logo

BioNTech

Recent Finacing

Equity

Recent Raise

$145M

BioNTech is a German biopharmaceutical company developing individualized mRNA vaccines and immunotherapies (CAR‑T, TCR, checkpoint modulators), integrating diagnostics, R&D and GMP manufacturing across Europe, US and Rwanda.

Founded 2008
Rheinland-Pfalz, Germany
5K-10K
Publicly Traded
biontech.com

Highlights

Focus Areas

Biopharma
Biotechnology
Life Science
Pharmaceutical

Recent Investors

Invus logo
S
Redmile Group logo
Fidelity Management & Research Company logo
Jebsen Capital logo
Platinum Asset Management logo
BVCF Management logo
Mirae Asset logo
S
Janus Henderson Investors logo
Coalition for Epidemic Preparedness Innovations logo
Sanofi logo

Financials

$831.2M

Total Raised

4

Funding rounds

12

Investors


Team

Upgrade to view the team

See the team members at BioNTech.